Relay Therapeutics Reports Third Quarter 2025 Financial Results and Corporate UpdatesGlobeNewsWire • 11/06/25
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in NovemberGlobeNewsWire • 11/03/25
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025GlobeNewsWire • 10/30/25
Wall Street Analysts Think Relay Therapeutics (RLAY) Could Surge 86.05%: Read This Before Placing a BetZacks Investment Research • 10/30/25
Here's Why Relay Therapeutics, Inc. (RLAY) is a Great Momentum Stock to BuyZacks Investment Research • 10/28/25
Wall Street Analysts Believe Relay Therapeutics (RLAY) Could Rally 116.91%: Here's is How to TradeZacks Investment Research • 10/14/25
Relay Therapeutics, Inc. (RLAY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/10/25
Relay Therapeutics (RLAY) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 08/12/25
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Beats Revenue EstimatesZacks Investment Research • 08/07/25
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate UpdatesGlobeNewsWire • 08/07/25
Relay Therapeutics to Announce Second Quarter 2025 Financial Results and Corporate Highlights on August 7, 2025GlobeNewsWire • 07/31/25
RXRX vs. RLAY: Which Precision Biotech Stock is a Better Bet Now?Zacks Investment Research • 07/25/25
Relay Therapeutics Announces Updated Data for RLY-2608 + Fulvestrant Further Demonstrating Clinically Meaningful Progression Free Survival at ASCO 2025GlobeNewsWire • 06/02/25
Relay Therapeutics Reports First Quarter 2025 Financial Results and Corporate UpdatesGlobeNewsWire • 05/05/25
Relay Therapeutics to Announce First Quarter 2025 Financial Results and Corporate Highlights on May 5, 2025GlobeNewsWire • 04/28/25